Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Circulation. 2006;113:60-66
Published online before print December 27, 2005, doi: 10.1161/CIRCULATIONAHA.105.560771
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/1/60    most recent
CIRCULATIONAHA.105.560771v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arimoto, T.
Right arrow Articles by Kubota, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arimoto, T.
Right arrow Articles by Kubota, I.
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies

(Circulation. 2006;113:60-66.)
© 2006 American Heart Association, Inc.

Heart Failure

Cardiac-Specific Overexpression of Diacylglycerol Kinase {zeta} Prevents Gq Protein-Coupled Receptor Agonist-Induced Cardiac Hypertrophy in Transgenic Mice

Takanori Arimoto, MD; Yasuchika Takeishi, MD; Hiroki Takahashi, MD; Tetsuro Shishido, MD; Takeshi Niizeki, MD; Yo Koyama, MD; Ryoko Shiga, MD; Naoki Nozaki, MD; Osamu Nakajima, PhD; Kazuhide Nishimaru, PhD; Jun-ichi Abe, MD; Masao Endoh, MD; Richard A. Walsh, MD; Kaoru Goto, MD; Isao Kubota, MD

From the First Department of Internal Medicine (T.A., Y.T., H.T., T.S., T.N., Y.K., R.S., N.N., I.K.), Research Laboratory for Molecular Genetics (O.N.), Department of Cardiovascular Pharmacology (K.N., M.E.), and Department of Anatomy and Cell Biology (K.G.), Yamagata University School of Medicine, Yamagata, Japan; Center for Cardiovascular Research, University of Rochester, Rochester, NY (J.A.); and Department of Medicine, Case Western Reserve University, Cleveland, Ohio (R.A.W.).

Reprint requests to Yasuchika Takeishi, MD, First Department of Internal Medicine, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, Japan 990-9585. E-mail takeishi{at}med.id.yamagata-u.ac.jp

Received July 20, 2004; de novo received May 10, 2005; revision received October 6, 2005; accepted October 17, 2005.

Background— Diacylglycerol is a lipid second messenger that accumulates in cardiomyocytes when stimulated by Gq{alpha} protein-coupled receptor (GPCR) agonists such as angiotensin II, phenylephrine, and others. Diacylglycerol functions as a potent activator of protein kinase C (PKC) and is catalyzed by diacylglycerol kinase (DGK) to form phosphatidic acid and inactivated. However, the functional roles of DGK have not been previously examined in the heart. We hypothesized that DGK might prevent GPCR agonist-induced activation of diacylglycerol downstream signaling cascades and subsequent cardiac hypertrophy.

Methods and Results— To test this hypothesis, we generated transgenic (DGK{zeta}-TG) mice with cardiac-specific overexpression of DGK{zeta}. There were no differences in heart size and heart weight between DGK{zeta}-TG and wild-type littermate mice. The left ventricular function was normal in DGK{zeta}-TG mice. Continuous administration of subpressor doses of angiotensin II and phenylephrine caused PKC translocation, gene induction of atrial natriuretic factor, and subsequent cardiac hypertrophy in WT mice. However, in DGK{zeta}-TG mice, neither translocation of PKC nor upregulation of atrial natriuretic factor gene expression was observed after angiotensin II and phenylephrine infusion. Furthermore, in DGK{zeta}-TG mice, angiotensin II and phenylephrine failed to increase cross-sectional cardiomyocyte areas and heart to body weight ratios. Phenylephrine-induced increases in myocardial diacylglycerol levels were completely blocked in DGK{zeta}-TG mouse hearts, suggesting that DGK{zeta} regulated PKC activity by controlling cellular diacylglycerol levels.

Conclusions— These results demonstrated the first evidence that DGK{zeta} negatively regulated the hypertrophic signaling cascade and resultant cardiac hypertrophy in response to GPCR agonists without detectable adverse effects in in vivo hearts.


Key Words: angiotensin • hypertrophy • enzymes • signal transduction




This article has been cited by other articles:


Home page
 Physiol. Rev.Home page
S. F. Steinberg
Structural Basis of Protein Kinase C Isoform Function
Physiol Rev, October 1, 2008; 88(4): 1341 - 1378.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
T. Kitahara, Y. Takeishi, M. Harada, T. Niizeki, S. Suzuki, T. Sasaki, M. Ishino, O. Bilim, O. Nakajima, and I. Kubota
High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice
Cardiovasc Res, October 1, 2008; 80(1): 40 - 46.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Urashima, M. Zhao, R. Wagner, G. Fajardo, S. Farahani, T. Quertermous, and D. Bernstein
Molecular and physiological characterization of RV remodeling in a murine model of pulmonary stenosis
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1351 - H1368.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
C. Hu, A. Dandapat, L. Sun, M. R. Marwali, N. Inoue, F. Sugawara, K. Inoue, Y. Kawase, K.-i. Jishage, H. Suzuki, et al.
Modulation of Angiotensin II-Mediated Hypertension and Cardiac Remodeling by Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Deletion
Hypertension, September 1, 2008; 52(3): 556 - 562.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
T. Niizeki, Y. Takeishi, T. Kitahara, T. Arimoto, M. Ishino, O. Bilim, S. Suzuki, T. Sasaki, O. Nakajima, R. A. Walsh, et al.
Diacylglycerol kinase-{varepsilon} restores cardiac dysfunction under chronic pressure overload: a new specific regulator of G{alpha}q signaling cascade
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H245 - H255.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. O. Rybin, J. Guo, Z. Gertsberg, S. J. Feinmark, and S. F. Steinberg
Phorbol 12-Myristate 13-Acetate-dependent Protein Kinase C{delta}-Tyr311 Phosphorylation in Cardiomyocyte Caveolae
J. Biol. Chem., June 27, 2008; 283(26): 17777 - 17788.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. P. Alibin, M. A. Kopilas, and H. D. I. Anderson
Suppression of Cardiac Myocyte Hypertrophy by Conjugated Linoleic Acid: ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS {alpha} AND {gamma}
J. Biol. Chem., April 18, 2008; 283(16): 10707 - 10715.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
M. Endoh
Novel signalling cascade for cardiac hypertrophy activation by uncoupling and internalization of {beta}1-adrenoceptors
Cardiovasc Res, April 1, 2008; 78(1): 5 - 7.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Crotty, J. Cai, F. Sakane, A. Taketomi, S. M. Prescott, and M. K. Topham
Diacylglycerol kinase {delta} regulates protein kinase C and epidermal growth factor receptor signaling
PNAS, October 17, 2006; 103(42): 15485 - 15490.
[Abstract] [Full Text] [PDF]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.